Advances in Glaucoma Testing
Chat Highlights
September 8, 2004
Norma Devine, Editor
On Wednesday, September 8, 2004, Dr. Rick Wilson, a glaucoma specialist
at Wills, and the glaucoma chat group discussed "Advances
in Glaucoma Testing."
Moderator: Tonight's
topic is "Advances in Glaucoma Testing."
P: Dr. Wilson, will you please
start with the HRT (Heidelberg Retinal Tomograph)?
Dr. Rick Wilson: The HRT is an instrument
that uses computerized imaging to map the surface of the optic
nerve. It is hoped that it will give an objective means
of following the optic nerve, rather than the doctor observing
it and comparing it to previous photographs.
P: But is it really of much help
to a glaucoma specialist?
Dr. Rick Wilson: For glaucoma specialists
who are expert in looking at optic nerves, the HRT is a slight
help. It can give a more objective way of measuring the
size of the optic nerve, IF the doctor himself or herself maps
out the outline. In most offices, a technician does the
mapping, and the original numbers may be highly inaccurate.
Since the original outline is maintained from then on, the numbers
may be meaningless, but the comparison may be accurate between
exams.
P: Is the optic disc area
delineated by the technician at the time the images are made,
or by the doctor evaluating the images afterward? Should
that be done by the same observer each time? I don't see how the
test can be reliable if the disk isn't drawn by the same person
each time.
Dr. Rick Wilson: The optic disc area
is outlined after the images are made by looking at the image
on the computer monitor. Because the images are not in color,
it is hard to see the edge of the nerve. When the outline of the
disc is made, the computer remembers it from then on and puts
it in the same place, right or wrong.
P: I'm baffled. My HRT
computer images were in color, and the technician altered the
outline the second time around. The new outline showed up
on the printout.
Dr. Rick Wilson: The image you see
is not in natural color. A new outline can be drawn at any
time, but then none of the numbers mean anything for comparison.
P: When clinicians speak of the
need for the HRT software to evolve for it to have any real utility,
does that necessarily refer to the correct placement of the disc
outline, or are there other variables that need to be better evaluated?
Dr. Rick Wilson: We need the computer
to be able to find the edge of the disc reliably. We also
need the accuracy of the scan to improve, as well as the repeatability
(that is, getting the same measurements on two exams just minutes
apart).
P: What advances have there been
in the HRT?
Dr. Rick Wilson: The advances are slow but
sure. If the test is repeated several times for a baseline,
comparisons with repeated tests later may be as accurate as good
examinations of the optic nerve.
P: What is the GDx nerve fiber
analyzer?
Dr. Rick Wilson: It is a machine that
uses the polarization of light as it passes through the retinal
nerve fiber layer (NFL) to measure the thickness of the layer.
Since glaucoma kills nerve cells and their fibers, the NFL thins
as the disease progress.
P: Have there been any improvements
in the GDx?
Dr. Rick Wilson: There was a large
improvement about two years ago. The manufacturer was able
to compensate for the polarization induced by the cornea and subtract
it, leaving mainly the polarization induced by the NFL.
P: Have there been improvements
in OCT (Ocular Coherence Tomography)?
Dr. Rick Wilson: We are using the OCT
III, which was only a slight improvement over the OCT II.
However, I have seen images from the prototype of OCT IV, and they were
wonderfully detailed -- a large improvement. When OCT IV comes
out, that will be THE machine.
Moderator: What kind of imaging
is OCT?
Dr. Rick Wilson: OCT uses the coherence
of light to give 3D images of tissue. The increased frequency
of the light provides finer details.
P: What single diagnostic tool
for glaucoma available today would you most have liked to have
had when you first became a glaucoma specialist?
Dr. Rick Wilson: Corneal pachymetry.
Corneal pachymeters measure the thickness of the cornea.
I would also liked to have known that the central corneal thickness
(CCT) can have such a significant effect on the IOP (intraocular
pressure) measurement.
P: Dr. Wilson, for two-and-a-half
years, I have been treated for normal-tension glaucoma.
My intraocular pressures range between 17 and 22 mm Hg (with and
without drops); I have a notch in the rim of the optic nerve,
and a scotoma in one eye only. My visual fields have shown
no progression. Because of several dermatological problems
and sensitivities, I can't seem to tolerate the eyedrops.
Today, my ophthalmologist recommended laser surgery. My central corneal
thickness has not been measured, and I think that should come
first. If I have normal-tension glaucoma, I would like to
be monitored without treatment. Can you comment, please?
Dr. Rick Wilson: It's hard to comment
without seeing you. I agree that corneal thickness measurements
should come first. I would also try non-preserved timolol
from Merck, if you can take beta-blockers. Many people who
are allergic to many of the eyedrops are allergic to the preservatives
in the drops and not the actual medicine. The risk-benefit of
the laser would depend upon your age and what the pigment is like
in your trabecular meshwork.
P: Two years ago, during a chat
session here, one of your colleagues mentioned a developing form
of visual field testing that uses electrodes to directly register
brain activity. He called it "multifocal visual evoked response."
Is that test available anywhere? If so, how good is it?
Dr. Rick Wilson: I heard a lecture about that
by Ivan Goldberg from Australia. It holds promise because it would be
wonderful to have a machine that measured vision objectively without the
vagaries of patient input. The problem with the objective visual field
is that the distance between the visual cortex that perceives the light
stimulus and the electrode on the outside of the skull varies, so there are
two variables. One is the amount of light the patient perceives; the
other is the distance from the cortex to the electrode.
Moderator: Are there any other
advances in visual field testing?
Dr. Rick Wilson: SWAP (short wavelength
automated perimetry), the blue-on-yellow visual field test, has
been around for some years now. It is the most sensitive
of the visual field tests for detecting new glaucoma. Because
it is so sensitive, there is more "noise," so it is harder to
interpret the results.
P: The importance of the central
corneal thickness (CCT) measurement can be considered an outcome
of the OHTS (Ocular Hypertension Treatment Study). Are there
any other diagnostic tests that have become more valuable because
of clinical studies?
Dr. Rick Wilson: We have learned more
about the reliability of white-on-white visual field tests.
In the CIGTS (Collaborative Initial Glaucoma Treatment Study)
and AGIS (Advanced Glaucoma Treatment Study), we found that when
a visual field looked significantly worse on one test, if it was
rechecked two more times, only one time out of three would there
be real progression. Therefore, if I see a visual field
that appears to have become worse, I repeat it before acting on
the belief that the patient's vision is worse.
P: In what way is automated perimetry
more useful in diagnosing glaucoma than it was 10 or 12 years
ago?
Dr. Rick Wilson: The statistical packages
that help us determine if the visual field is abnormal or has
progressed are more sophisticated and can be trusted more. They
give a statistical probability of whether each point on the visual
field is worse.
Moderator: Thank you for being
here tonight, Dr. Wilson.
Dr. Rick Wilson: You're welcome.
Tomorrow I'm going to Columbia to speak at a symposium, and from
there to Shenyang, China, for a week, as a visiting professor.
Moderator: Have a safe trip.
End of highlights for September 8, 2004.
On September 22, 2004, Dr. Wilson discussed "Glaucoma Medications" in the Chat room. Click here for highlights
of that meeting.
Click here for the most recent
glaucoma chat highlights and links to the chat archives.
Click here for
upcoming glaucoma chat events.
|